John Sheridan

John Sheridan

President and Chief Executive OfficeratTandem Diabetes Care· In proxies 2021–2025

Pay in FY2025-20% from the year before · Tandem Diabetes Care stock -39.0% the same year

John Sheridan was paid $6.9M in FY2025 (Dec), down 20%. Tandem Diabetes Care stock fell 39.0% that year.

Pay$100 in the stock at the end of FY20 → $23
Pay is from the Summary Compensation Table of each Tandem Diabetes Care proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tandem Diabetes CarePublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrStock in role -79%
  2. Acutus Medical, Inc.Public company · 4 yr
    • Director2021 – 2025 · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?